Design of greener drugs: aligning parameters in pharmaceutical R&D and drivers for environmental impact

Active pharmaceutical ingredients (APIs) in the environment, primarily resulting from patient excretion, are of concern because of potential risks to wildlife. This has led to more restrictive regulatory policies. Here, we discuss the ‘benign-by-design’ approach, which encourages the development of...

Full description

Saved in:
Bibliographic Details
Published in:Drug discovery today 2024-07, Vol.29 (7), p.104022, Article 104022
Main Authors: Vidaurre, Rodrigo, Bramke, Irene, Puhlmann, Neele, Owen, Stewart F., Angst, Daniela, Moermond, Caroline, Venhuis, Bastiaan, Lombardo, Anna, Kümmerer, Klaus, Sikanen, Tiina, Ryan, Jim, Häner, Andreas, Janer, Gemma, Roggo, Silvio, Perkins, Alison Nimrod
Format: Article
Language:English
Subjects:
bioaccumulation
chemical mobility
ecotoxicity
environmentally benign
human health
persistence
safe and sustainable by design SSbD
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Active pharmaceutical ingredients (APIs) in the environment, primarily resulting from patient excretion, are of concern because of potential risks to wildlife. This has led to more restrictive regulatory policies. Here, we discuss the ‘benign-by-design’ approach, which encourages the development of environmentally friendly APIs that are also safe and efficacious for patients. We explore the challenges and opportunities associated with identifying chemical properties that influence the environmental impact of APIs. Although a straightforward application of greener properties could hinder the development of new drugs, more nuanced approaches could lead to drugs that benefit both patients and the environment. We advocate for an enhanced dialogue between research and development (R&D) and environmental scientists and development of a toolbox to incorporate environmental sustainability in drug development.
ISSN:1359-6446
1878-5832
1878-5832
DOI:10.1016/j.drudis.2024.104022